04.03.2015 - AstraZeneca has completed its acquisition of the rights to Actavis' branded respiratory business in the US and Canada. The UK-Swedish drugmaker said the buy strengthens its...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)